Lewis Darwin purchased $6K of LFVN

Lewis Darwin purchased 705 shares of Lifevantage Corp (LFVN) at $8.60 on 2026-06-15 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Lewis Darwin
Published Jun 17, 2026, 8:05 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 17, 2026, 8:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LFVN
Bullish
medium confidence
Mentioned
$LFVN
Relevance
3/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LFVNBullishLow
01

Why it matters

The disclosure adds incremental sentiment information (director buying) but does not include any new company fundamentals, guidance, or regulatory/operational catalyst.

02

Market read

A small director open-market buy is disclosed via SEC EDGAR; it may slightly support sentiment but is unlikely to drive major repricing alone.

03

What to watch

The article provides only one small buy; traders may want to check for prior insider activity trends, total insider ownership, and whether other directors/officers are also buying or selling.

Relevance 3/10Novelty 6/10Timing: SEC Form 4 filed 2026-06-17 (after the 2026-06-15 purchase)

Background

The article is an SEC Form 4 insider transaction disclosure for Lifevantage Corp, reporting a director’s open-market purchase under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$LFVNBullishMedium confidence
Context

Lifevantage (LFVN) disclosed a director open-market purchase: Lewis Darwin bought 705 shares at $8.5950 on 2026-06-15 under a 10b5-1 plan.

Expected impact

Low likelihood of a sustained move; any reaction is likely muted unless followed by additional disclosures or company-specific catalysts.

Evidence & confidence

The filing is primary-source (SEC Form 4) and shows a director purchase, but the dollar value (~$6.1k) is small and there is no accompanying operational or financial news.

Market effects

No clear sector read-through; this is an individual insider transaction without broader industry/regulatory context.

None indicated.

None indicated.

Counterpoint

A 10b5-1 plan purchase may be pre-scheduled rather than a fresh signal, reducing interpretive value for near-term trading.

Key entities

  • Lifevantage Corp

    Subject of the Form 4 insider transaction disclosure.

  • Lewis Darwin

    Director who purchased 705 shares of LFVN at $8.5950/share on 2026-06-15.

  • 10b5-1 plan

    Pre-arranged plan noted as Yes, implying the trade may be scheduled rather than discretionary.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LFVNMed

LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026

Lifevantage Corp (LFVN) filed an SEC Form 8-K — Results of Operations and Financial Condition. LifeVantage Announces Financial Results for the Fourth Fiscal Quarter and Full Fiscal Year 2026 Salt Lake City, UT, August 27, 2026 , LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with products designed to activate optimal health processes at the c